Solid Power, Inc. - Quarter Report: 2023 June (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2023
or
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from _______ to _______
Commission file number: 001-40284
SOLID POWER, INC.
(Exact name of registrant as specified in its charter)
Delaware |
| 86-1888095 |
(State or other jurisdiction of | (I.R.S. Employer | |
incorporation or organization) | Identification No.) | |
486 S. Pierce Ave., Suite E | ||
Louisville, Colorado | 80027 | |
(Address of principal executive offices) | (Zip Code) |
(303) 219-0720
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
| Trading symbol(s) |
| Name of each exchange on which registered |
Common stock, par value $0.0001 per share | SLDP | The Nasdaq Stock Market LLC | ||
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 | SLDPW | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☒ | | Accelerated filer ☐ | | Non-accelerated filer ☐ | | Smaller reporting company ☒ |
| | Emerging growth company ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
178,390,443 shares of common stock were issued and outstanding as of August 7, 2023.
SOLID POWER, INC.
FORM 10-Q
Table of Contents
| ||
6 | ||
Management’s Discussion and Analysis of Financial Condition and Results of Operations | 17 | |
22 | ||
22 | ||
| | |
| ||
22 | ||
22 | ||
23 | ||
| | |
| 24 |
1
GLOSSARY OF DEFINED TERMS
Term | | Definition |
Ah | | Ampere hour |
BMW | | BMW of North America LLC |
ESPP | | Solid Power, Inc. 2021 Employee Stock Purchase Plan |
EV | | Battery electric vehicle |
EV cells | | Prototype cell formats between 60 and 100 Ah |
EV line | | Our pilot cell production line that is capable of producing cells between 60 and 100 Ah. |
Exchange Act | | Securities Exchange Act of 1934, as amended |
Ford | | Ford Motor Company |
GAAP | | Generally accepted accounting principles in the United States |
JDA | | Joint development agreement |
OEM | | Automotive original equipment manufacturers |
Q1 Form 10-Q | | Our Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 |
Report | | This Quarterly Report on Form 10-Q |
SEC | | Securities and Exchange Commission |
Solid Power / the Company / we / us / our | | Solid Power, Inc., a Delaware corporation (f/k/a Decarbonization Plus Acquisition Corporation III) |
SP2 | | Our Thornton, CO facility that houses electrolyte development |
2022 Form 10-K | | Our Annual Report on Form 10-K for the year ended December 31, 2022 |
2
Cautionary Note Regarding Forward-Looking Statements
This Report contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. We have based these forward-looking statements on our current expectations and projections about future events. All statements, other than statements of present or historical fact included in this Report, regarding our future financial performance and our strategy, expansion plans, market opportunity, future operations, future operating results, estimated revenues or losses, projected costs, prospects, plans, and objectives of management are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “will,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “continue,” “project,” or the negative of such terms or other similar expressions. These forward-looking statements are subject to known and unknown risks, uncertainties, and assumptions about us that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by such forward-looking statements. Except as otherwise required by applicable law, we disclaim any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this Report. We caution you that the forward-looking statements contained herein are subject to numerous risks and uncertainties, most of which are difficult to predict and many of which are beyond our control.
In addition, we caution you that the forward-looking statements regarding the Company contained in this Report are subject to the following factors:
● | risks relating to the uncertainty of the success of our research and development efforts, including our ability to achieve the technological objectives or results that our partners require, and to commercialize our technology in advance of competing technologies; |
● | risks relating to the non-exclusive nature of our original equipment manufacturers and JDA relationships; |
● | our ability to negotiate and execute supply agreements with our partners on commercially reasonable terms; |
● | rollout of our business plan and the timing of expected business milestones; |
● | delays in the construction and operation of production facilities; |
● | our ability to protect our intellectual property, including in jurisdictions outside of the United States; |
● | broad market adoption of EVs and other technologies where we are able to deploy our cell technology and electrolyte material, if developed successfully; |
● | our success in retaining or recruiting, or changes required in, our officers, key employees, including technicians and engineers, or directors; |
● | risks and potential disruptions related to management and board of directors transitions; |
● | changes in applicable laws or regulations; |
● | risks related to technology systems and security breaches; |
● | the possibility that we may be adversely affected by other economic, business or competitive factors, including supply chain interruptions, and may not be able to manage other risks and uncertainties; |
● | risks relating to our status as a research and development stage company with a history of financial losses, and an expectation to incur significant expenses and continuing losses for the foreseeable future; |
● | the termination or reduction of government clean energy and electric vehicle incentives; |
● | changes in domestic and foreign business, market, financial, political and legal conditions; and |
3
● | those factors discussed in “Part I, Item 1A. Risk Factors” in our 2022 Form 10-K and in “Part II, Item 1A. Risk Factors” in our Q1 Form 10-Q, as such descriptions may be updated or amended in future filings we make with the SEC. |
We caution you that the foregoing list does not contain all of the risks or uncertainties that could affect the Company.
You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Report primarily on our current expectations and projections about future events and trends that we believe may affect our business, operating results, financial condition and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors, including those described in “Part I, Item 1A. Risk Factors” in our 2022 Form 10-K and “Part II, Item 1A. Risk Factors” in our Q1 Form 10-Q, as such descriptions may be updated or amended in future filings we make with the SEC. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Report. We cannot assure you that the results, events, and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements.
Neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. Moreover, the forward-looking statements made in this Report relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Report to reflect events or circumstances after the date of this Report or to reflect new information or the occurrence of unanticipated events, except as required by law. You should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments we may make.
TRADEMARKS
Our logo and trademark appearing in this Report and the documents incorporated by reference herein are our property. This document and the documents incorporated by reference herein contains references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this Report may appear without the ® or TM symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies’ trade names, trademarks, or service marks to imply a relationship with, or endorsement or sponsorship of it by, any other companies.
MARKET AND INDUSTRY DATA
We obtained the industry and market data used throughout this Report or any documents incorporated herein by reference from our own internal estimates and research, as well as from independent market research, industry and general publications and surveys, governmental agencies, publicly available information, and research, surveys, and studies conducted by third parties. Internal estimates are derived from publicly available information released by industry analysts and third-party sources, our internal research, and our industry experience and are based on assumptions made by us based on such data and our knowledge of our industry and market, which we believe to be reasonable. In some cases, we do not expressly refer to the sources from which this data is derived. In addition, while we believe the industry and market data included in this Report or any documents incorporated herein by reference is reliable and based on reasonable assumptions, such data involve material risks and other uncertainties and is subject to change based on various factors, including those discussed in the section entitled “Risk Factors.” These and other factors could cause results to differ materially from those expressed in the estimates made by the independent parties or by us.
4
INFORMATION ABOUT SOLID POWER
We use our website (www.solidpowerbattery.com) and various social media channels as a means of disclosing information about Solid Power and our products to our customers, investors, and the public (e.g., @SolidPowerInc on Twitter, Solid Power Inc. on LinkedIn, and Solid Power on YouTube). The information posted on our website and social media channels is not incorporated by reference in this Report or in any other report or document we file with the SEC. Further, references to our website URLs are intended to be inactive textual references only. The information we post through these channels may be deemed material. Accordingly, investors should monitor these channels, in addition to following our press releases, SEC filings, and public conference calls and webcasts. In addition, you may automatically receive e-mail alerts and other information about Solid Power when you enroll your e-mail address by visiting the “Investor Email Alerts” section of our website at https://ir.solidpowerbattery.com. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to reports filed pursuant to Sections 13(a) and 15(d) of the Exchange Act are filed with the SEC. These reports and other information we file with the SEC are available free of charge at https://ir.solidpowerbattery.com/financial-information/sec-filings when such reports are available on the SEC’s website.
5
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
Solid Power, Inc.
Condensed Consolidated Balance Sheets
(in thousands, except par value and number of shares)
June 30, 2023 | |||||||
| (Unaudited) |
| December 31, 2022 | ||||
Assets | |||||||
Current Assets |
|
|
|
| |||
Cash and cash equivalents | $ | 28,439 | $ | 50,123 | |||
Marketable securities | 192,694 | 272,957 | |||||
Contract receivables |
| 5,224 |
| 1,840 | |||
Prepaid expenses and other current assets |
| 3,494 |
| 2,888 | |||
Total current assets |
| 229,851 |
| 327,808 | |||
Property, Plant and Equipment, net |
| 95,076 |
| 82,761 | |||
Right-Of-Use Operating Lease Asset, net | 7,444 | 7,725 | |||||
Right-Of-Use Financing Lease Asset, net | 938 | 922 | |||||
Other Assets | 1,087 | 1,148 | |||||
Long-term Investments | 222,255 | 172,974 | |||||
Intangible Assets, net |
| 1,360 |
| 1,108 | |||
Total assets | $ | 558,011 | $ | 594,446 | |||
Liabilities and Stockholders’ Equity |
|
| |||||
Current Liabilities |
|
| |||||
Accounts payable and other accrued liabilities | 8,065 | 11,326 | |||||
Current portion of long-term debt |
| — |
| 7 | |||
Deferred revenue |
| 18 |
| 4,050 | |||
Accrued compensation |
| 4,080 |
| 4,528 | |||
Operating lease liabilities, short-term | 586 | 549 | |||||
Financing lease liability, short-term | 308 | 273 | |||||
Total current liabilities |
| 13,057 |
| 20,733 | |||
Warrant Liabilities | 6,791 | 9,117 | |||||
Operating Lease Liabilities, Long-Term | 8,317 | 8,622 | |||||
Financing Lease Liabilities, Long-Term |
| 535 |
| 602 | |||
Total liabilities | 28,700 | 39,074 | |||||
Stockholders’ Equity |
|
|
|
| |||
Common Stock, $0.0001 par value; 2,000,000,000 shares authorized; 178,326,890 and 176,007,184 shares and as of June 30, 2023 and December 31, 2022, respectively |
| 18 |
| 18 | |||
Additional paid-in capital |
| 583,034 | 577,603 | ||||
Accumulated deficit |
| (50,369) |
| (19,090) | |||
Accumulated other comprehensive loss | (3,372) | (3,159) | |||||
Total stockholders’ equity |
| 529,311 |
| 555,372 | |||
Total liabilities and stockholders’ equity | $ | 558,011 | $ | 594,446 |
See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).
6
Solid Power, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited)
(in thousands, except number of shares and per share amounts)
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||
2023 |
| 2022 | 2023 |
| 2022 | ||||||||
Revenue | $ | 4,906 | $ | 2,582 | $ | 8,698 | $ | 4,778 | |||||
Operating Expenses |
|
| |||||||||||
Direct costs | 6,897 | 2,987 | 13,171 | 5,017 | |||||||||
Research and development | 14,508 |
| 8,440 | 26,156 |
| 15,101 | |||||||
Selling, general and administrative | 5,673 |
| 5,851 | 12,862 |
| 10,670 | |||||||
Total operating expenses | 27,078 |
| 17,278 | 52,189 |
| 30,788 | |||||||
Operating Loss | (22,172) |
| (14,696) | (43,491) |
| (26,010) | |||||||
Nonoperating Income and Expense |
|
| |||||||||||
Interest income | 4,993 | 931 | 9,827 | 1,171 | |||||||||
Change in fair value of warrant liabilities | 4,987 | 27,473 | 2,325 | 28,183 | |||||||||
Interest expense | (13) |
| (5) | (26) |
| (10) | |||||||
Total nonoperating income and expense | 9,967 |
| 28,399 | 12,126 |
| 29,344 | |||||||
Pretax Income (Loss) | (12,205) |
| 13,703 | (31,365) |
| 3,334 | |||||||
Income tax benefit | — |
| 36 | — |
| 13 | |||||||
Net Income (Loss) Attributable to Common Stockholders | $ | (12,205) | $ | 13,667 | $ | (31,365) | $ | 3,321 | |||||
Other Comprehensive Income (Loss) | 1,098 | (961) | (213) | (1,291) | |||||||||
Comprehensive Income (Loss) Attributable to Common Stockholders | $ | (11,107) | $ | 12,706 | $ | (31,578) | $ | 2,030 | |||||
Basic and diluted earnings (loss) per share | (0.07) | 0.08 | (0.18) | 0.02 | |||||||||
Weighted average shares outstanding – basic | 178,063,573 |
| 174,128,230 | 177,502,037 |
| 173,266,760 | |||||||
Weighted average shares outstanding – diluted | 178,063,573 |
| 174,703,533 | 177,502,037 |
| 173,566,001 |
See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).
7
Solid Power, Inc.
Condensed Consolidated Statement of Stockholders’ Equity (Unaudited)
(in thousands, except number of shares)
Common Stock | ||||||||||||||||||
Additional | Accumulated | Accumulated Other | Total Stockholders’ | |||||||||||||||
| Shares |
| Amount |
| paid-in capital |
| deficit |
| Comprehensive Loss |
| Equity | |||||||
Balance as of December 31, 2022 | 176,007,184 | $ | 18 | $ | 577,603 | $ | (19,090) | $ | (3,159) | $ | 555,372 | |||||||
Net loss |
| — |
| — | — |
| (19,158) | — |
| (19,158) | ||||||||
Stock options exercised |
| 1,679,954 |
| — | 150 |
| — | — |
| 150 | ||||||||
Stock-based compensation expense |
| — |
| — | 2,222 |
| — | — |
| 2,222 | ||||||||
Unrealized gain on marketable securities | — | — | — | — | 885 | 885 | ||||||||||||
Balance as of March 31, 2023 | 177,687,138 | $ | 18 | $ | 579,975 | $ | (38,248) | $ | (2,274) | $ | 539,471 | |||||||
Net loss |
| — |
| — | — |
| (12,205) | — |
| (12,205) | ||||||||
Shares issued under ESPP | 129,928 | — | 214 | — | — | 214 | ||||||||||||
Withholding of employee taxes related to stock-based compensation | — | — | (111) | 84 | — | (27) | ||||||||||||
Shares issued for vested RSUs | 163,148 | — | — | — | — | |||||||||||||
Stock options exercised |
| 346,676 |
| — | 33 |
| — | — |
| 33 | ||||||||
Stock-based compensation expense |
| — |
| — | 2,923 |
| — | — |
| 2,923 | ||||||||
Unrealized loss on marketable securities | — | — | — | — | (1,098) | (1,098) | ||||||||||||
Balance as of June 30, 2023 | 178,326,890 | $ | 18 | $ | 583,034 | $ | (50,369) | $ | (3,372) | $ | 529,311 |
Common Stock | ||||||||||||||||||
Additional | Accumulated | Accumulated Other | Total Stockholders’ | |||||||||||||||
| Shares |
| Amount |
| paid-in capital |
| deficit |
| Comprehensive Loss |
| Equity | |||||||
Balance as of December 31, 2021 | 167,557,988 | $ | 17 | $ | 568,183 | $ | (9,535) | $ | — | $ | 558,665 | |||||||
Net loss |
| — |
| — | — |
| (10,344) | — |
| (10,344) | ||||||||
Transaction fees | — | — | (12) | — | — | (12) | ||||||||||||
Stock options exercised |
| 6,212,964 |
| — | 270 |
| — | — |
| 270 | ||||||||
Stock-based compensation expense |
| — |
| — | 1,596 |
| — | — |
| 1,596 | ||||||||
Unrealized loss on marketable securities | — | — | — | — | (330) | (330) | ||||||||||||
Balance as of March 31, 2022 | 173,770,952 | $ | 17 | $ | 570,037 | $ | (19,879) | $ | (330) | $ | 549,845 | |||||||
Net income (loss) |
| — | — | — | 13,667 | — | 13,667 | |||||||||||
Withholding of employee taxes related to stock-based compensation | — | — | (58) | — | — | (58) | ||||||||||||
Shares issued for the vesting of RSUs | 20,672 | — | — | — | — | — | ||||||||||||
Stock options exercised |
| 656,180 | — | 163 | — | — | 163 | |||||||||||
Stock-based compensation expense |
| — | — | 2,314 | — | — | 2,314 | |||||||||||
Unrealized loss on marketable securities |
| — | — | — | — | (961) | (961) | |||||||||||
Balance as of June 30, 2022 | 174,447,804 | $ | 17 | $ | 572,456 | $ | (6,212) | $ | (1,291) | $ | 564,970 |
See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).
8
Solid Power, Inc.
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
Six Months Ended June 30, | |||||||
| 2023 |
| 2022 | ||||
Cash Flows from Operating Activities |
| ||||||
Net income (loss) | $ | (31,365) | $ | 3,321 | |||
Adjustments to reconcile net income (loss) to net cash and cash equivalents from operating activities: |
| ||||||
Depreciation and amortization | 4,906 |
| 1,782 | ||||
Amortization of right-of-use assets | 372 | 16 | |||||
Stock compensation expense | 5,145 |
| 3,910 | ||||
Deferred taxes | — |
| 13 | ||||
Change in fair value of warrant liabilities | (2,325) | (28,183) | |||||
Amortization of premiums and accretion of discounts on marketable securities | (5,518) | — | |||||
Change in operating assets and liabilities that provided (used) cash and cash equivalents: |
| ||||||
Contract receivable | (3,383) |
| (1,202) | ||||
Prepaid expenses and other assets | (188) |
| 744 | ||||
Accounts payable and other accrued liabilities | (297) |
| (4,261) | ||||
Deferred revenue | (4,032) |
| (286) | ||||
Accrued expenses | 649 |
| 1,000 | ||||
Lease liabilities | (268) | 188 | |||||
Net cash and cash equivalents used in operating activities | (36,304) |
| (22,958) | ||||
Cash Flows from Investing Activities |
| ||||||
Purchases of property, plant and equipment | (21,184) |
| (30,957) | ||||
Purchases of marketable securities and long-term investments | (174,400) |
| (212,792) | ||||
Proceeds from sales of marketable securities | 210,329 | 54,819 | |||||
Purchases of intangible assets | (259) |
| (228) | ||||
Net cash and cash equivalents provided by (used in) investing activities | 14,486 |
| (189,158) | ||||
Cash Flows from Financing Activities |
| ||||||
Payments of debt | (7) |
| (71) | ||||
Proceeds from exercise of stock options | 184 |
| 354 | ||||
Proceeds from issuance of common stock under ESPP | 214 | — | |||||
Receivable for exercise of stock options | — | 79 | |||||
Cash paid for withholding of employee taxes related to stock-based compensation | (111) | (58) | |||||
Payments on finance lease liability | (146) | (20) | |||||
Transaction costs | — | (12) | |||||
Net cash and cash equivalents provided by financing activities | 134 | 272 | |||||
Net (decrease) in cash and cash equivalents | (21,684) | (211,844) | |||||
Cash and cash equivalents at beginning of period | 50,123 | 513,447 | |||||
Cash and cash equivalents at end of period | 28,439 | 301,603 | |||||
Cash paid for interest | $ | 26 | $ | 5 | |||
Accrued capital expenditures | $ | 3,591 | $ | 8,146 |
See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).
9
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 – Nature of Business
Solid Power, Inc. (the “Company”) is developing solid state battery technology to enable the next generation of batteries for the fast-growing EV and other markets. The Company’s planned business model is to sell its sulfide-based solid electrolyte and to license its solid-state cell designs and manufacturing process.
Note 2 – Significant Accounting Policies
The significant accounting policies followed by the Company are set forth in Note 2 – Significant Accounting Policies to the Company’s financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “2022 Form 10-K”) and are supplemented by the Notes to the Condensed Consolidated Financial Statements (Unaudited) (the “Notes”) included in this Quarterly Report on Form 10-Q for the period ended June 30, 2023 (this “Report”). The financial statements included in this Report (including the Notes) should be read in conjunction with the 2022 Form 10-K.
Basis of Presentation and Principles of Consolidation
The accompanying unaudited condensed consolidated financial statements of the Company have been prepared on the basis of generally accepted accounting principles in the United States (“GAAP”). The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts reported in the unaudited condensed consolidated financial statements. Actual results could differ from those estimates. All dollar amounts presented herein are in U.S. dollars and are in thousands, except par value, share and per share amounts.
The accompanying unaudited condensed consolidated financial statements include accounts of the Company and its wholly owned subsidiary, Solid Power Operating, Inc. All intercompany balances and transactions have been eliminated in consolidation. Additionally, certain prior period amounts have been reclassified to conform to current period presentation in the accompanying unaudited condensed consolidated financial statements.
Recent Accounting Pronouncements
Leases
In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), followed by other related ASUs that provided targeted improvements and additional practical expedient options. On January 1, 2022, the Company adopted the standards under Topic 842 using the modified retrospective method and elected a number of the practical expedients in its implementation of Topic 842. The key change that affected the Company relates to accounting for operating leases for which it is the lessee that were historically off-balance sheet.
Financial Instruments
In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This guidance introduces a new model for recognizing credit losses on financial instruments based on an estimate of current expected credit losses. ASU 2016-13 also provides updated guidance regarding the impairment of available-for-sale debt securities and includes additional disclosure requirements. The Company adopted this guidance as of January 1, 2022.
The Company regularly reviews its available-for-sale marketable securities and evaluates the current expected credit losses by considering factors such as any changes in credit ratings, historical experience, market data, issuer-specific factors, and current economic conditions. Based on this analysis, any allowance for credit losses is immaterial and would be recorded as a reduction to the carrying value of the asset.
The Company reviews its receivable aging on an individual customer level, considering collectability of cash flows based on the risk of past events, current conditions, and forward-looking information. The Company establishes allowances for bad debts equal to the estimable portions of accounts receivable for which failure to collect is expected to occur. Allowances for doubtful accounts are recorded as reductions to the carrying values of the related receivables. To date, the Company has not recorded an allowance for doubtful accounts.
10
Note 3 – Property, Plant and Equipment
Property, plant and equipment are summarized as follows:
| June 30, 2023 |
| December 31, 2022 | ||||
Commercial production equipment | $ | 25,454 | $ | 21,595 | |||
Laboratory equipment | 7,554 | 3,278 | |||||
Leasehold improvements |
| 45,581 |
| 27,996 | |||
Furniture and computer equipment |
| 1,634 |
| 1,482 | |||
Construction in progress |
| 31,317 |
| 40,036 | |||
Total cost |
| 111,540 |
| 94,387 | |||
Accumulated depreciation |
| (16,464) |
| (11,626) | |||
Net property and equipment | $ | 95,076 | $ | 82,761 |
Depreciation expenses for dedicated laboratory equipment and commercial production equipment are charged to research and development. The other depreciation expenses are included in the Company’s overhead and are allocated across operating expenses on the accompanying Condensed Consolidated Statements of Operations based on Company personnel costs incurred.
Depreciation expense related to property, plant, and equipment are summarized as follows:
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||
| 2023 |
| 2022 | 2023 |
| 2022 | |||||||
Depreciation expense | $ | 2,639 | $ | 1,026 | $ | 4,898 | $ | 1,777 |
In 2022, the Company expanded its cell production capabilities through the construction of a second dry room and installation of a second cell pilot production line at its Louisville, Colorado facility, which is designed to produce larger format solid-state battery cells for the automotive qualification process.
The Company expanded its electrolyte production at its facility in Thornton, Colorado. Scaling this production will allow it to produce larger quantities of electrolyte material required to feed cell-production lines and continue research and development efforts. The Company began producing electrolyte at this facility in 2023 and has placed portions of the facility into service.
June 30, 2023 | December 31, 2022 | ||||||
Construction in progress | |||||||
EV cell line (SP1) | $ | 1,083 | $ | 2,010 | |||
Other cell development equipment (SP1) | 2,703 | 2,206 | | ||||
Electrolyte production and development equipment (SP2) | 27,531 | 35,820 | |
Note 4 – Intangible Assets
Intangible assets of the Company are summarized as follows:
| June 30, 2023 |
| December 31, 2022 | ||||||||||
Gross Carrying | Accumulated | Gross Carrying | Accumulated | ||||||||||
| Amount |
| Amortization |
| Amount |
| Amortization | ||||||
Intangible assets: | |||||||||||||
Licenses | $ | 149 | $ | (56) | $ | 149 | $ | (51) | |||||
Patents | 72 | (3) | — | — | |||||||||
Patents pending |
| 1,168 |
| — |
| 984 |
| — | |||||
Trademarks | 13 | — | 9 | — | |||||||||
Trademarks pending |
| 17 |
| — |
| 17 |
| — | |||||
Total amortized intangible assets | $ | 1,419 | $ | (59) | $ | 1,159 | $ | (51) |
11
Amortization expense for intangible assets is summarized as follows:
Three Months Ended June 30, | Six Months Ended June 30, |
| |||||||||||
| 2023 |
| 2022 | 2023 |
| 2022 |
| ||||||
Amortization expense | $ | 3 | $ | 2 | $ | 8 | $ | 5 |
Useful lives of intangible assets range from to 20 years. Amortization expenses are allocated ratably across operating expenses on the accompanying condensed consolidated statements of operations.
Note 5 – Fair Value Measurements
The carrying amounts of certain financial instruments, such as cash equivalents, short-term investments, accounts receivable, accounts payable, and accrued liabilities, approximate fair value due to their relatively short maturities.
Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis
As of June 30, 2023 and December 31, 2022, the Company’s financial assets and liabilities measured and recorded at fair value on a recurring basis were classified within the fair value hierarchy as follows:
June 30, 2023 | ||||||||||||
| Level 1 |
| Level 2 |
| Level 3 |
| Total | |||||
Assets | ||||||||||||
Commercial Paper | $ | 137,072 | $ | — | $ | — | $ | 137,072 | ||||
Corporate Bonds | $ | 216,390 | $ | — | $ | — | $ | 216,390 | ||||
Government Bonds | $ | 61,487 | $ | — | $ | — | $ | 61,487 | ||||
U.S. Treasuries |
| — | — | — |
| — | ||||||
Liabilities | ||||||||||||
Public Warrants | $ | 3,932 | $ | — | $ | — | $ | 3,932 | ||||
Private Placement Warrants | $ | — | $ | 2,859 | $ | — | $ | 2,859 |
December 31, 2022 | ||||||||||||
| Level 1 |
| Level 2 |
| Level 3 |
| Total | |||||
Assets | ||||||||||||
Commercial Paper | $ | 165,179 | $ | — | $ | — | $ | 165,179 | ||||
Corporate Bonds | $ | 227,957 | $ | — | $ | — | $ | 227,957 | ||||
Government Bonds | $ | 42,865 | $ | — | $ | — | $ | 42,865 | ||||
U.S. Treasuries |
| 9,930 | — | — |
| 9,930 | ||||||
Liabilities | ||||||||||||
Public Warrants | $ | 4,900 | $ | — | $ | — | $ | 4,900 | ||||
Private Placement Warrants | $ | — | $ | 4,217 | $ | — | $ | 4,217 |
The change in fair value of the Company’s marketable securities and long-term investments are included in other comprehensive loss. There were no transfers in and out of Level 3 fair value hierarchy during the three or six months ended June 30, 2023 or year ended December 31, 2022. For the three and six months ended June 30, 2023, the Company purchased $174,400 of marketable securities.
Fair Value of Warrants
The fair value of the Private Placement Warrants (defined below) has been estimated using a Black-Scholes model as of June 30, 2023 and December 31, 2022 Consolidated Balance Sheet dates. The fair value of the Public Warrants (defined below) has been measured based on the quoted price of such warrants on the Nasdaq Stock Market, a Level 1 input. The estimated fair value of the Private Placement Warrants is determined using Level 2 inputs. Inherent in a Black-Scholes model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. Material increases (or decreases) in any of those inputs may result in a significantly higher (or lower) fair value measurement. The Company estimates the volatility of its Private Placement Warrants based on implied volatility from the Company’s Public Warrants and from historical volatility of select peer
12
companies’ common stock that matches the expected remaining life of the Warrants (defined below). The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve for a maturity similar to the expected remaining life of the Warrants. The expected life of the Warrants is assumed to be equivalent to their remaining contractual term. The dividend yield is based on the historical rate, which the Company anticipates remaining at zero. The following table provides quantitative information regarding Level 2 inputs used in the recurring valuation of the Private Placement Warrants as of their measurement dates:
| June 30, 2023 |
| December 31, 2022 |
| |||
Exercise Price | $ | 11.50 | $ | 11.50 | |||
Stock Price | $ | 2.54 | $ | 2.54 | |||
Volatility |
| 70.0 | % |
| 71.3 | % | |
Term |
| 3.44 |
| 3.94 | |||
Risk-free rate |
| 4.32 | % |
| 4.03 | % |
The following table provides a reconciliation of the Public Warrants measured at fair value using Level 1 directly observable inputs and Private Placement Warrants measured at fair value using Level 2 directly or indirectly observable inputs:
| Public Warrants | | Private Placement Warrants | |||
| Level 1 Fair Value |
| Level 2 Fair Value | |||
December 31, 2022 | $ | 0.42 | $ | 0.55 | ||
Change in fair value | $ | 0.04 | $ | 0.31 | ||
March 31, 2023 | $ | 0.46 | $ | 0.86 | ||
Change in fair value | $ | (0.15) | $ | (0.43) | ||
June 30, 2023 | $ | 0.31 | $ | 0.43 |
The following tables provides a reconciliation of the June 30, 2023 three and six month change in fair value for the Public Warrants and Private Placement Warrants:
Three months change in | |||||||||||||
Warrant Class |
| Level |
| Warrants |
| March 31, 2023 |
| fair value |
| June 30, 2023 | |||
Public Warrants |
| 1 |
| 12,684,423 | $ | 5,576 | $ | (1,644) | $ | 3,932 | |||
Private Placement Warrants |
| 2 |
| 6,648,880 | $ | 6,203 | $ | (3,343) | $ | 2,860 | |||
Total |
|
|
| 19,333,303 | $ | 11,779 | $ | (4,987) | $ | 6,792 |
Six months change in | |||||||||||||
Warrant Class |
| Level |
| Warrants |
| December 31, 2022 |
| fair value |
| June 30, 2023 | |||
Public Warrants |
| 1 |
| 12,684,423 | $ | 4,900 | $ | (968) | $ | 3,932 | |||
Private Placement Warrants |
| 2 |
| 6,648,880 | $ | 4,217 | $ | (1,357) | $ | 2,860 | |||
Total |
|
|
| 19,333,303 | $ | 9,117 | $ | (2,325) | $ | 6,792 |
Note 6 – Warrant Liabilities
As of June 30, 2023 and December 31, 2022, there were 12,684,423 and 11,666,636 publicly traded warrants (“Public Warrants”) and 6,648,880 and 7,666,667 private placement warrants (“Private Placement Warrants,” and together with the Public Warrants, “Warrants”) outstanding, respectively. Each whole Warrant entitles the holder thereof to purchase one share of Common Stock at a price of $11.50 per share, subject to customary adjustments. Only whole Warrants are exercisable. The Warrants became exercisable on January 7, 2022 and will expire on December 8, 2026.
None of the Private Placement Warrants are redeemable by the Company so long as they are held by the initial purchasers of the Private Placement Warrants or their permitted transferees.
The Warrants were initially measured at fair value upon closing of the transactions contemplated by the Business Combination Agreement and Plan of Reorganization, dated June 15, 2021 by and among the Company, DCRC Merger Sub, Inc., and Solid Power Operating, Inc., as amended, for $101,253 and subsequently re-measured at each reporting period. The Public Warrants were allocated a portion of the proceeds from the issuance of the units of common stock and one-third warrants in Decarbonization Plus Acquisition Corporation III’s initial public offering equal to their fair value. The Company recognized a gain in connection with
13
changes in the fair value of warrant liabilities of $4,987 and $2,325 for the three and six months ending June 30, 2023 and $27,473 and $28,183 for the three and six months ending June 30, 2022, respectively.
There have been no changes to our Public or Private Placement Warrants, including redemption terms disclosed in our 2022 Form 10-K.
Note 7 – Stockholders’ Equity
Common Stock
Stock options exercised for Common Stock, shares issued under the Solid Power, Inc. 2021 Employee Stock Purchase Plan (“ESPP”), and shares issued upon vesting of RSUs for the three and six months ended June 30, 2023 and 2022 are summarized in the table below:
Three months ended June 30, | Six months ended June 30, | ||||||||
| 2023 |
| 2022 | 2023 |
| 2022 | |||
Stock options exercised | 346,676 | 656,180 | 2,026,630 | 6,869,144 | |||||
Shares issued under ESPP | | 129,928 | — | 129,928 | — | | |||
Shares issued upon vesting of RSUs | | 163,148 | 20,672 | 163,148 | 20,672 | |
Cash received from stock options exercised under the Solid Power, Inc. 2014 Equity Incentive Plan (the “2014 Plan”) for the six months ended June 30, 2023 and 2022 was $184 and $354, respectively. Cash received from stock options exercised under the 2014 Plan for the three months ended June 30, 2023 and 2022 was $34 and $84, respectively.
Cash received from shares issued under the ESPP for the six months ended June 30, 2023 and 2022 was $214 and $0, respectively. Cash received from shares issued under the ESPP for the three months ended June 30, 2023 and 2022 was $214 and $0, respectively.
Note 8 – Stock Based Compensation
There have been no changes to our equity incentive plans, Employee Stock Purchase Plan, or accounting methodology for stock based compensation, as disclosed in our 2022 Form 10-K.
The fair value of stock options and Restricted Stock Units (“RSUs”) issued to employees and directors is recognized as compensation expense over the period of service that generally coincides with the vesting period of the award. The Company allocated compensation ratably across Operating Expenses. When calculating the amount of annual compensation expense, the Company has elected not to estimate forfeitures and instead accounts for forfeitures as they occur.
For the three and six months ended June 30, 2023, the Company recognized compensation costs totaling:
Three months ended June 30, | Six months ended June 30, | |||||||||||
| 2023 |
| 2022 | 2023 |
| 2022 | ||||||
Equity-based compensation costs related to RSUs | $ | 954 | $ | 514 | $ | 1,589 | $ | 514 | ||||
Equity-based compensation costs related to stock options |
| 1,889 |
| 1,800 |
| 3,476 |
| 3,396 | ||||
Equity-based compensation costs related to ESPP | 80 | — | 80 | — | ||||||||
Total equity-based compensation costs | $ | 2,923 | $ | 2,314 | $ | 5,145 | $ | 3,910 | ||||
Unrecognized future compensation cost as of | | | — | | | — | | | 34,327 | | | 25,316 |
14
The following table summarizes our award activity for RSUs and stock options for the three and six months ended June 30, 2023:
| |||||
RSUs | Stock Options | ||||
Balance at December 31, 2022 | 1,057,980 |
| 25,998,172 | ||
Granted | 1,797,034 | 3,272,873 | |||
Vested or Exercised | — | (1,679,954) | |||
Forfeited | (88,441) | (1,494,020) | |||
Balance at March 31, 2023 | 2,766,573 | 26,097,071 | |||
Granted | 1,753,207 | 1,904,016 | |||
Vested or Exercised | (215,553) | (346,676) | |||
Forfeited | (47,181) | (466,635) | |||
Outstanding at June 30, 2023 | 4,257,046 | 27,187,776 |
Stock Options
The fair value of each stock option grant during the six months ended June 30, 2023 and 2022 was estimated on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions used:
| Six months ended June 30, |
| ||||||
| 2023 |
| 2022 |
| ||||
Approximate risk‑free rate |
| 4.17 | % | 2.84 | % | |||
Volatility |
| 46.91 | % | 44.69 | % | |||
Average expected life (years) |
| 6 years | 6 years | |||||
Dividend yield |
| — | % | — | % | |||
Weighted‑average grant date fair value | $ | 2.80 | $ | 7.26 | ||||
Estimated fair value of total stock options granted | $ | 7,815 | $ | 5,659 |
Note 9 – Earnings (Loss) Per Share
Basic earnings (loss) per share represents net income (loss) attributable to common stock divided by the basic weighted average number of common stock outstanding during the period.
Due to the net loss for the three and six months ended June 30, 2023, diluted loss per share was computed without consideration to potentially dilutive instruments as their inclusion would have been anti-dilutive. Due to the net income for the three and six months ended June 30, 2022, diluted earnings per share was computed with consideration to potentially dilutive instruments. Warrants outstanding in 2023 and 2022 were not included in the computation of diluted earnings per share because the Warrant’s exercise price for the period was greater than the average market price of the common stock.
The table below sets forth the basic and diluted earnings (loss) per share calculation for the three and six months ended June 30, 2023 and 2022.
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||
| 2023 | 2022 | 2023 | 2022 | |||||||||
Net income (loss) attributable to common stockholders | $ | (12,205) | $ | 13,667 | $ | (31,365) | $ | 3,321 | |||||
Weighted average shares outstanding – basic | 178,063,573 | 174,128,230 | 177,502,037 | 173,266,760 | |||||||||
Weighted average shares outstanding – diluted | 178,063,573 | 174,703,533 | 177,502,037 | 173,566,001 | |||||||||
Basic and diluted earnings (loss) per share | (0.07) | 0.08 | (0.18) | 0.02 |
15
As of the three and six months ended June 30, 2023, potentially dilutive securities excluded from the diluted loss per share calculation are as illustrated in the table below. Additionally, for the three and six months ended June 30, 2022, potentially dilutive securities included from the diluted earnings per share calculation are as follows (in shares):
| Six Months Ended June 30, | | |||
| 2023 |
| 2022 | | |
Warrants | 19,333,303 |
| 19,333,303 | ||
2014 & 2021 Equity Incentive Plan - Stock Options | 25,892,666 |
| 27,161,312 | ||
2021 Equity Incentive Plan - RSUs | 2,474,393 |
| 1,674,284 | ||
2021 Employee Stock Purchase Plan - Common Stock | 46,352 | — | |||
Contingently Issuable Common Stock | 59,055 | — | |||
Total potentially dilutive securities | 47,805,769 | 48,168,899 |
Note 10 – Leases
The Company leases its two facilities and certain equipment. Fixed rent generally escalates each year, and the Company is responsible for a portion of the landlords’ operating expenses such as property tax, insurance, and common area maintenance.
The Company’s facility in Louisville, Colorado, is under a noncancelable operating lease with a maturity date in September 2029. In 2022, the Company amended the lease to incorporate a prior subleased space into the base lease and extend the term of the lease. The Company has the right to renew this lease for an additional five-year period.
On September 1, 2021, the Company entered into an industrial operating lease agreement for its facility in Thornton, Colorado, with the initial term through March 31, 2029. Under this operating lease, the Company has one option to renew for five years, which has been included in the calculation of lease liabilities and right-of-use assets at the adoption date of the lease accounting standard on January 1, 2022, as the exercise of the option was reasonably certain. As the renewal rent has not been negotiated, the Company used an estimated rent rate which approximated the fair market rent at adoption of ASC 842 on January 1, 2022 for the extension period.
The Company has certain equipment leases classified as finance leases as of June 30, 2023.
The Company’s leases do not have any contingent rent payments and do not contain residual value guarantees.
The components of lease expense are as follows:
| Three Months Ended |
| Six Months Ended | ||||
| June 30, 2023 |
| June 30, 2023 | ||||
Finance lease costs: |
|
|
|
| |||
Amortization of right-of-use assets | $ | 47 | $ | 91 | |||
Interest on lease liabilities |
| 13 |
| 25 | |||
Operating lease costs |
| 290 |
| 580 | |||
Total lease expense | $ | 350 | $ | 696 |
The components of cash flow information related to leases are as follows:
| Three Months Ended |
| Six Months Ended | ||||
| June 30, 2023 |
| June 30, 2023 | ||||
Operating outgoing cash flows – finance lease | $ | 14 | $ | 26 | |||
Financing outgoing cash flows – finance lease |
| 74 |
| 141 | |||
Operating outgoing cash flows – operating lease |
| 283 |
| 567 | |||
Right-of-use assets obtained in exchange for new finance lease liabilities: | | | 79 | 89 | | ||
Right-of-use assets obtained in exchange for new operating lease liabilities: | | | — | — | |
16
| June 30, 2023 |
| |
Finance lease |
|
| |
Weighted-average remaining lease term – finance lease (in years) |
| 2.98 | |
Weighted-average discount rate – finance lease |
| 6.2 | % |
Operating lease |
|
| |
Weighted-average remaining lease term – operating lease (in years) |
| 9.71 | |
Weighted-average discount rate – operating lease |
| 6.9 | % |
As of June 30, 2023, future minimum payments during the next five years and thereafter are as follows:
Fiscal year |
| Finance Lease |
| Operating Lease | ||
2023 (remaining six months) | $ | 174 | $ | 571 | ||
2024 | 349 | 1,173 | ||||
2025 | 234 | 1,210 | ||||
2026 | 109 | 1,248 | ||||
2027 | 37 | 1,288 | ||||
2028 | 16 | 1,329 | ||||
Thereafter | — | 5,244 | ||||
Total | 919 | 12,063 | ||||
Less present value discount | 77 | 3,158 | ||||
Total lease liabilities | $ | 842 | $ | 8,905 |
Note 11 – Related Party Transactions
During the three and six months ended June 30, 2023, the Company recognized $3,470 and $6,470, respectively, of revenue related to the BMW joint development agreement. As of June 30, 2023 the Company recorded $2,477 of accounts receivable related to the BMW joint development agreement.
Note 12 – Income Taxes
The Company’s effective tax rate was 0.00% and 0.27% for the three months ended June 30, 2023 and 2022, respectively, and 0.00% and 0.49% for the six months ended June 30, 2023 and 2022, respectively. The change in the effective tax rate between periods was due to the Company was being in a full valuation allowance for the three and six months ended June 30, 2023.
Note 13 – Contingencies
In the normal course of business, the Company may be party to litigation from time to time. The Company maintains insurance to cover certain actions and believes that resolution of such litigation will not have a material adverse effect on the Company.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the consolidated financial statements and related notes thereto included elsewhere in this Report. The following discussion contains forward-looking statements that reflect future plans, estimates, beliefs, and expected performance. For additional discussion, see “Cautionary Note Regarding Forward-Looking Statements” above. The forward-looking statements are dependent upon events, risks, and uncertainties that may be outside of our control. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed elsewhere in this Report, under Part I, Item 1A. “Risk Factors” of our 2022 Form 10-K, and under “Part II, Item 1A. Risk Factors” in our Q1 Form 10-Q, as such descriptions may be updated or amended in future filings we make with the SEC. Unless indicated otherwise, the following discussion and analysis of results of operations and financial condition and liquidity relates to our current continuing operations and should be read in conjunction with the consolidated financial statements and notes thereto of this Report and our 2022 Form 10-K. We do not undertake, and expressly disclaim, any obligation to publicly update any forward-looking statements, whether as a result of new information, new developments, or otherwise, except to the extent that such disclosure is required by applicable law.
17
Overview
We are developing solid state battery technologies to enable the next generation of rechargeable batteries for the fast-growing EV and other markets.
Our core technology is our proprietary sulfide-based solid electrolyte material, which replaces the liquid or gel electrolyte used in conventional lithium-ion batteries. We believe that our electrolyte material can enable extended driving range, longer battery life, improved safety, and lower costs compared to conventional lithium-ion.
We also are designing and developing solid state cells that utilize our electrolyte in the cathode, anode, and separator layers. We currently produce 0.2 Ah, 2 Ah, 20 Ah, and EV cells on two pilot lines using established manufacturing processes.
We have partnered with industry leaders, including Ford, BMW, and SK On Co., Ltd. We are working closely with each of these partners to refine and validate our cell designs and electrolyte material with the ultimate goal to commercialize our technologies. Our business model – selling our electrolyte to cell manufacturers and licensing our cell designs and manufacturing processes – distinguishes us from many of our competitors who plan to be commercial battery manufacturers. Ultimately, we endeavor to be a leading producer and distributor of sulfide-based solid electrolyte material for powering both EVs and other applications. Since we do not intend to commercially produce battery cells, we expect to invest less than other development-stage battery companies that plan to commercially manufacture their own cell designs and construct battery production facilities.
The products we currently make are in the development stage and require continued development and validation before we can commercialize either our electrolyte or cell technology.
Recent Business Highlights
● | SP2 commenced electrolyte powder production in April, began scaling production, and is meeting internal performance and quality targets. |
● | Continued execution on JDAs and extended JDA with Ford. |
● | Received positive feedback from industry leaders on initial electrolyte powder sampling activities. |
● | EV cell production increased and improved 20 Ah cell yields, keeping the company on track for 2023 delivery of A-sample EV cells to partners and delivery of EV cells to BMW for demo car program. |
● | Second half of 2023 is focused on continuing electrolyte scaling and sampling, optimizing cell production processes, improving cell performance, and delivering cells to partners. |
● | Appointed John Van Scoter as President and Chief Executive Officer. |
Key Factors Affecting Operating Results
We are a research and development-stage company and have not generated significant revenue through the sale of our electrolyte or licensing of our cell designs. Our ability to commercialize our products depends on several factors that present significant opportunities for us but also pose material risks and challenges, including those discussed in “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements,” appearing in this Report, which are incorporated by reference.
Prior to reaching commercialization, we must test and validate our products to ensure they meet the performance and safety requirements of our customers. We also will have to negotiate licensing and supply contracts with our customers on terms and conditions that are mutually acceptable. We will need to scale production of our electrolyte material to satisfy anticipated demand. All of these factors will take time and affect our operating results. Since many factors are difficult to quantify, our actual operating results may be different than we currently anticipate.
Our revenue generated to date has primarily come from research and development performance on government contracts and research and development licensing activities. We have deployed and are deploying substantial capital to expand our production
18
capabilities and engage in research and development programs. We also continue to incur significantly more administrative expenses as a publicly traded company.
In addition to meeting our development goals and reaching commercialization, future growth and demand for our products will be highly dependent upon market adoption of EVs. The market for new energy vehicles is still rapidly evolving due to emerging technologies, competitive pricing, government regulation and industry standards, and changing consumer demands and behaviors.
Basis of Presentation
We currently conduct our business through one operating segment. As a research and development company with no commercial operations, our activities to date have been limited and were conducted primarily in the United States. Our historical results are reported under GAAP and in U.S. dollars.
Results of Operations
Comparison of the Three and Six Months Ended June 30, 2023 to the Three and Six Months Ended June 30, 2022
During the three and six months ended June 30, 2023, we expanded and accelerated our development efforts through increased capital and operational investments. We continued to invest in talent while expanding our facilities, production equipment, and capabilities. We expect to continue to increase our spending in all operational areas through the remainder of 2023 in order to execute our development strategy.
The following table is a consolidated summary of our operating results for the periods indicated:
Three Months Ended June 30, |
| Six Months Ended June 30, |
| ||||||||||||||||||||||
(in thousands) |
| 2023 |
| 2022 |
| Change |
| % |
| 2023 |
| 2022 |
| Change |
| % |
| | |||||||
Revenue | $ | 4,906 | $ | 2,582 | $ | 2,324 | 90 | % | $ | 8,698 | $ | 4,778 | $ | 3,920 | 82 | % | |||||||||
Operating Expenses |
|
|
|
|
|
|
| ||||||||||||||||||
Direct costs | 6,897 | 2,987 |
| 3,910 |
| 131 | % |
| 13,171 | 5,017 |
| 8,154 |
| 163 | % | ||||||||||
Research and development | 14,508 |
| 8,440 |
| 6,068 |
| 72 | % |
| 26,156 | 15,101 |
| 11,055 |
| 73 | % | |||||||||
Selling, general and administrative | 5,673 |
| 5,851 |
| (178) |
| (3) | % |
| 12,862 | 10,670 |
| 2,192 |
| 21 | % | |||||||||
Total operating expenses | 27,078 |
| 17,278 |
| 9,800 |
| 57 | % |
| 52,189 | 30,788 |
| 21,401 |
| 70 | % | |||||||||
Operating Loss | (22,172) |
| (14,696) |
| (7,476) |
| (51) | % |
| (43,491) | (26,010) |
| (17,481) |
| (67) | % | |||||||||
Nonoperating Income and Expense |
|
|
|
|
|
|
|
|
| ||||||||||||||||
Interest income | 4,993 | 931 |
| 4,062 |
| 436 | % |
| 9,827 | 1,171 |
| 8,656 |
| 739 | % | ||||||||||
Change in fair value of warrant liabilities | 4,987 | 27,473 | (22,486) | (82) | % | 2,325 | 28,183 | (25,858) | (123) | % | |||||||||||||||
Interest expense | (13) | (5) |
| (8) |
| 160 | % |
| (26) | (10) |
| (16) |
| 160 | % | ||||||||||
Total nonoperating income and expense | 9,967 |
| 28,399 | $ | (18,432) |
| (65) | % | $ | 12,126 | 29,344 | $ | (17,218) |
| (59) | % | |||||||||
Pretax Income (Loss) | (12,205) |
| 13,703 | (25,908) | NM | (31,365) | 3,334 | (34,699) | NM | ||||||||||||||||
Income tax benefit | — |
| 36 |
| (36) |
| NM |
| — | 13 |
| (13) |
| NM | |||||||||||
Net Income (Loss) | $ | (12,205) | $ | 13,667 |
| (25,872) |
| NM |
| (31,365) | $ | 3,321 |
| (34,686) |
| NM | |||||||||
Net Income (Loss) Attributable to Common Stockholders | $ | (12,205) | $ | 13,667 | $ | (25,872) |
| NM | $ | (31,365) | $ | 3,321 | $ | (34,686) |
| NM | |||||||||
Other Comprehensive Income (Loss) | 1,098 | (961) | 2,059 |
| NM |
| (213) | (1,291) | 1,078 |
| NM | ||||||||||||||
Comprehensive Income (Loss) Attributable to Common Stockholders | $ | (11,107) | $ | 12,706 | $ | (23,813) |
| NM | $ | (31,578) | $ | 2,030 | $ | (33,608) |
| NM |
NM = Not meaningful
19
The key factors driving our results of operations for the three and six months ended June 30, 2023, including our increased operating loss as compared to the corresponding periods in 2022, were as follows:
● | Revenue and direct costs – revenue and related direct costs from the execution of our JDAs drove the overall increase for the periods, while revenue and direct costs from performance on government contracts decreased slightly. We expect revenue and related direct costs to increase in the second half of 2023 as we execute on JDA deliverables and continue to provide samples to third parties and potential customers. |
● | Research and development – our research and development costs increased for the periods primarily as a result of increased labor and material costs as we expanded the development efforts of our battery cells and electrolyte material. We expect our development costs to continue to increase as we continue to accelerate both the pace and scope of our development efforts. |
● | Selling, general and administrative – our selling, general and administrative costs decreased in the three months ended June 30, 2023 primarily due to reduced use of outside professional services and increased in the six months ended June 30, 2023 primarily due to additional planned hiring, and workforce development and training, as we have increased our headcount to over 250 people, as well as enterprise resource planning system costs and implementation efforts. |
● | Operating expenses – non-cash stock compensation costs for the periods increased across direct costs, research and development costs, and selling, general and administrative expenses related to our increased headcount. |
● | Nonoperating income – our nonoperating income decreased for the periods primarily due to loss on fair value adjustment of warrant liabilities, partially offset by strategic cash investments in A-rated investments, which increased both our interest income and other income. |
Liquidity and Capital Resources
Sources of Liquidity
Our sources of cash have historically been primarily derived from the sale of equity, with a small portion coming from performance on government contracts and commercial revenues.
As of June 30, 2023 and December 31, 2022, we had total liquidity, as set forth below:
(in thousands) |
| June 30, 2023 | December 31, 2022 | ||||
Cash and cash equivalents | $ | 28,439 | $ | 50,123 | |||
Marketable securities |
| 192,694 |
| 272,957 | |||
Long-term investments |
| 222,255 |
| 172,974 | |||
Total liquidity | $ | 443,388 | $ | 496,054 |
Short-Term Liquidity Requirements
We anticipate that our most significant capital expenditures for the remainder of 2023 will relate to finishing construction of our electrolyte production and development facility. In addition, our short-term liquidity requirements include operating and capital expenses needed to further our technology development programs. We expect to fund our short-term liquidity requirements through our cash on hand and other liquid assets.
Long-Term Liquidity Requirements
We believe that our cash on hand is sufficient to meet our operating cash needs (including expenditures for the increased pace and scope of development as well as increased public company costs) and working capital and capital expenditure requirements for a period of at least the next 12 months and longer term until we generate adequate cash flows from licensing activities and/or electrolyte sales.
20
We may, however, need additional cash if there are material changes to our business conditions or other developments, including changes to our operating plan, development progress, delays in negotiations with OEMs, cell manufacturers, or other suppliers, market adoption of EVs, supply chain challenges, competitive pressures, inflation, and regulatory developments. To the extent that our resources are insufficient to satisfy our cash requirements, we may need to seek additional equity or debt financing. We also may opportunistically seek to enhance our liquidity through equity or debt financing, if such financing becomes available to us on terms that we consider favorable. If the financing is not available, or if the terms of financing are less desirable than we expect, we may be forced to take actions to reduce our capital or operating expenditures, which may adversely affect our development, business, operating results, financial condition, and prospects.
Cash Flows
The following table summarizes our cash flows from operating, investing, and financing activities for the periods presented:
Six Months Ended June 30, | |||||||
(in thousands) |
| 2023 |
| 2022 | |||
Net cash used in operating activities | $ | (36,304) | $ | (22,958) | |||
Net cash provided by (used in) investing activities | $ | 14,486 | $ | (189,158) | |||
Net cash provided by financing activities | $ | 134 | $ | 272 |
Cash used in operating activities:
Cash used in operating activities increased from June 30, 2022 to 2023. The increase was primarily attributable to our operating loss, which was driven by continued increase in research and development costs and selling, general and administrative expenses. We continue to expect cash used in operating activities to increase as we accelerate both the pace and scope of our development efforts and work to achieve commercialization of our products. We continue to anticipate increased expenditures for research and development and selling, general and administrative functions to support growth of our development efforts. In addition, we expect to incur increased operating expenses in the second half of 2023 as we execute on BMW JDA deliverables.
Cash flows provided by (used in) investing activities:
Cash provided by investing activities increased from June 30, 2022 to 2023 primarily due to the net effect of increased purchase and sales of marketable securities partially offset by increases in capital expenditures and patent investments. Capital expenditures were primarily for custom manufacturing equipment in connection with our expansion of electrolyte production capabilities. We expect cash used in investing activities to increase as we finalize the build out of our electrolyte production facility and increase its production capabilities, and as we increase our electrolyte production scale. Each of our locations will continue to require investment in specialized equipment to facilitate the manufacturing process of our electrolyte material and battery cells. As our production processes are scaled in the future, especially with respect to our electrolyte material, we expect capital expenditures to increase.
Cash flows provided by financing activities:
Net cash provided by financing activities for the six months ended June 30, 2023 and 2022 was primarily from the cash exercise of stock options and proceeds from the sale of common stock under the ESPP.
Off-Balance Sheet Arrangements
We are not a party to any off-balance sheet arrangements, as defined under SEC rules.
Critical Accounting Estimates
Except as discussed in Note 2 of our unaudited financial statements included in this Report, there were no significant and material changes in our critical accounting policies and use of estimates during the three and six months ended June 30, 2023, as compared to those disclosed in “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates” in our 2022 Form 10-K.
21
Recent Accounting Pronouncements
See Note 2 to our audited financial statements included in our 2022 Form 10-K for more information.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are a smaller reporting company as defined in Rule 12b-2 under the Exchange Act. As a result, pursuant to Item 305(e) of Regulation S-K, we are not required to provide the information required by this Item.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
In designing and evaluating our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired controls. As required by Rule 13a-15(b) under the Exchange Act, our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2023. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of the end of the period covered by this Report, our disclosure controls and procedures were effective.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the three months ended June 30, 2023 covered by this Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II – OTHER INFORMATION
Item 1. Legal Proceedings
From time to time, we may become involved in litigation or other legal proceedings. We are not currently a party to any litigation or legal proceedings that are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.
Item 1A. Risk Factors
Our business, prospects, reputation, results of operations and financial condition, as well as the price of our common stock and warrants, can be affected by a number of factors, whether currently known or unknown, including those described in “Part I, Item 1A. Risk Factors” of our 2022 Form 10-K and “Part II, Item 1A. Risk Factors” of our Q1 Form 10-Q, as such descriptions may be updated or amended in future filings we make with the SEC. When any one or more of these risks materialize from time to time, our business, reputation, results of operations and financial condition, as well as the price of our common stock and warrants, can be materially and adversely affected. There have been no material changes to our risk factors since our Q1 Form 10-Q.
22
Item 6. Exhibits
| | | | Incorporated by Reference | ||||||
Exhibit Number | | Description | | Schedule Form | | File Number | | Exhibit/Annex | | Filing Date |
2.1 | | | 424B3 | | 333-258681 | | Annex A | | November 10, 2021 | |
2.2 | | | 424B3 | | 333-258681 | | Annex A-1 | | November 10, 2021 | |
3.1 | | | 8-K | | 001-40284 | | 3.1 | | December 13, 2021 | |
3.2 | | | 8-K | | 001-40284 | | 3.1 | | November 21, 2022 | |
10.1± | | | 8-K | | 001-40284 | | 10.1 | | July 5, 2023 | |
10.2# | | | 8-K | | 001-40284 | | 10.1 | | May 31, 2023 | |
31.1* | | Certification Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934 | | | | | | | | |
31.2* | | Certification Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934 | | | | | | | | |
32.1** | | | | | | | | | | |
32.2** | | | | | | | | | | |
101.INS* | | XBRL Instance Document – the instance document does not appear in the Interactive Data file because its Inline XBRL tags are embedded within the Inline XBRL document. | | | | | | | | |
101.SCH* | | Inline XBRL Taxonomy Extension Schema Document | | | | | | | | |
101.CAL* | | Inline XBRL Taxonomy Extension Calculation Linkbase | | | | | | | | |
101.DEF* | | Inline XBRL Taxonomy Extension Definition Document | | | | | | | | |
101.LAB* | | Inline XBRL Taxonomy Extension Label Linkbase Document | | | | | | | | |
101.PRE* | | Inline XBRL Taxonomy Extension Presentation Linkbase | | | | | | | | |
104* | | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | | | | | | | | |
* Filed herewith.
** Furnished herewith.
± Certain portions of this exhibit have been omitted in accordance with Regulation S-K Item 601. The Company agrees to furnish an unredacted copy of the exhibit to the SEC upon request.
# Indicates a management or compensatory plan.
23
SIGNATURE
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: August 9, 2023 | Solid Power, Inc. |
| By: | /s/ John Van Scoter |
| Name: | John Van Scoter |
| Title: | President, Chief Executive Officer, and Director |
| (Principal Executive Officer) |
| By: | /s/ Kevin Paprzycki |
| Name: | Kevin Paprzycki |
| Title: | Chief Financial Officer and Treasurer |
| (Principal Financial and Accounting Officer) |
24